FTC, AbbVie Seek Quick Wins In Androgel Antitrust Suit
The Federal Trade Commission and a host of pharmaceutical companies on Monday filed dueling summary judgment bids in the FTC's Pennsylvania case accusing the drugmakers of filing sham patent litigation against...To view the full article, register now.
Already a subscriber? Click here to view full article